(Q36347470)

13 August 2017

title

WNT5A regulates adipose tissue angiogenesis via antiangiogenic VEGF-A165b in obese humans (English)

1 reference

13 August 2017

0 references

angiogenesis inhibitor

1 reference

7

Brian Carmine

1 reference

13 August 2017

Shakun Karki

1

1 reference

13 August 2017

Doan T M Ngo

2

1 reference

13 August 2017

Melissa G Farb

3

1 reference

13 August 2017

Song Young Park

4

1 reference

13 August 2017

Samantha M Saggese

5

1 reference

13 August 2017

Naomi M Hamburg

6

1 reference

13 August 2017

Donald T Hess

8

1 reference

13 August 2017

Kenneth Walsh

9

1 reference

13 August 2017

Noyan Gokce

10

1 reference

13 August 2017

publication date

14 April 2017

1 reference

American Journal of Physiology Heart and Circulatory Physiology

13 August 2017

published in

1 reference

13 August 2017

volume

313

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

H200-H206

1 reference

Defective Wnt Signaling: A Potential Contributor to Cardiometabolic Disease?

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

VEGF 165 b in the developing vasculatures of the fetal human eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Therapeutic potential of inhibitory VEGF splice variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Insulin status and vascular responses to weight loss in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Ectopic fat depots and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Impaired local microvascular vasodilatory effects of insulin and reduced skin microvascular vasomotion in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Arteriolar function in visceral adipose tissue is impaired in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Forkhead box O-1 modulation improves endothelial insulin resistance in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Perioperative safety in the longitudinal assessment of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Reduced oxygenation in human obese adipose tissue is associated with impaired insulin suppression of lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Vascular rarefaction mediates whitening of brown fat in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

Health and economic burden of the projected obesity trends in the USA and the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00776.2016

VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma

21 January 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6148084

2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults

12 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28411232

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1152/AJPHEART.00776.2016

1 reference

13 August 2017

0 references

1 reference